High dose MOPEVAC-Las vaccine: Clinical Trials

1 trial of High dose MOPEVAC-Las vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow High dose MOPEVAC-Las vaccine: new trials by email Literature Review of High dose MOPEVAC-Las vaccine trials Research Report on High dose MOPEVAC-Las vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever
Low dose MOPEVAC-Las vaccine, Intermediate dose MOPEVAC-Las vaccine, High dose MOPEVAC-Las vaccine - Lassa Fever
Phase 1RecruitingInstitut Pasteur722026-09-282026-10-13

Conditions studied

Lassa Fever (1)

Sponsors

Institut Pasteur (1)

Countries

France (1)

Top investigators

Sylvain Baize (1)